Ferumoxytol
Side effects
Options:
Hide MedDRA Preferred Terms
|
MedDRA Preferred Term
|
Side effect
|
Data for drug
|
Placebo
|
Labels
|
|
|
1
|
2
|
|
Nausea
|
Nausea
|
postmarketing, 3.1% - 7.5%
|
|
x
|
x
|
|
Oedema peripheral
|
Oedema peripheral
|
2% - 3.2%
|
|
x
|
|
|
Headache
|
Headache
|
postmarketing, 1.8% - 2.1%
|
|
x
|
x
|
|
Vomiting
|
Vomiting
|
postmarketing, 1.5% - 5%
|
|
x
|
x
|
|
Oedema
|
Oedema
|
1.4% - 1.5%
|
|
x
|
|
|
Abdominal pain
|
Abdominal pain
|
postmarketing, 1.3% - 1.4%
|
|
x
|
x
|
|
Gastrointestinal pain
|
Abdominal pain
|
postmarketing, 1.3% - 1.4%
|
|
x
|
x
|
|
Cough
|
Cough
|
postmarketing, 1.3% - 1.4%
|
|
x
|
x
|
|
Constipation
|
Constipation
|
postmarketing, 2.1%
|
|
x
|
x
|
|
Dyspnoea
|
Dyspnoea
|
postmarketing, 1% - 1.1%
|
|
x
|
x
|
|
Muscle spasms
|
Muscle spasms
|
postmarketing, 1% - 1.4%
|
|
x
|
x
|
|
Dizziness
|
Dizziness
|
postmarketing, 1.8% - 2.6%
|
|
x
|
x
|
|
Syncope
|
postmarketing
|
|
x
|
x
|
|
Body temperature increased
|
Body temperature increased
|
postmarketing, 0.7% - 1%
|
|
x
|
x
|
|
Fever chills
|
postmarketing
|
|
|
x
|
|
Hypertension
|
Hypertension
|
postmarketing, 1%
|
|
x
|
x
|
|
Chest pain
|
Chest pain
|
postmarketing, 0.7% - 1.3%
|
|
x
|
x
|
|
Chest discomfort
|
postmarketing
|
|
|
x
|
|
Dermatitis
|
Rash
|
postmarketing, 0.4% - 1%
|
|
x
|
x
|
|
Rash
|
Rash
|
postmarketing, 0.4% - 1%
|
|
x
|
x
|
|
Pruritus
|
Pruritus
|
postmarketing, 0.4% - 1.2%
|
|
x
|
x
|
|
Abdominal distension
|
Abdominal distension
|
postmarketing
|
|
|
x
|
|
Anaphylactic shock
|
Anaphylactic shock
|
postmarketing
|
|
|
x
|
|
Anaphylactoid reaction
|
postmarketing
|
|
|
x
|
|
Angioedema
|
Angioedema
|
postmarketing
|
|
x
|
x
|
|
Arrhythmia
|
Arrhythmia
|
postmarketing
|
|
|
x
|
|
Arthralgia
|
Arthralgia
|
postmarketing
|
|
|
x
|
|
Musculoskeletal discomfort
|
Arthralgia
|
postmarketing
|
|
|
x
|
|
Myalgia
|
postmarketing
|
|
|
x
|
|
Asthenia
|
Asthenia
|
postmarketing
|
|
|
x
|
|
Fatigue
|
postmarketing
|
|
|
x
|
|
Back pain
|
Back pain
|
postmarketing, 0% - 1%
|
|
x
|
x
|
|
Bronchospasm
|
Bronchospasm
|
postmarketing
|
|
|
x
|
|
Contusion
|
Contusion
|
postmarketing
|
|
|
x
|
|
Cyanosis
|
Cyanosis
|
postmarketing
|
|
x
|
x
|
|
Dehydration
|
Dehydration
|
postmarketing
|
|
|
x
|
|
Diarrhoea
|
Diarrhoea
|
postmarketing, 4%
|
|
x
|
x
|
|
Dysgeusia
|
Dysgeusia
|
postmarketing
|
|
|
x
|
|
Dyspepsia
|
Dyspepsia
|
postmarketing
|
|
|
x
|
|
Ecchymosis
|
Ecchymosis
|
postmarketing
|
|
x
|
x
|
|
Eosinophilia
|
Eosinophilia
|
postmarketing
|
|
|
x
|
|
Epistaxis
|
Epistaxis
|
postmarketing
|
|
|
x
|
|
Eye disorder
|
Eye disorder
|
postmarketing
|
|
|
x
|
|
Fatigue
|
Fatigue
|
postmarketing
|
|
|
x
|
|
Flushing
|
Flushing
|
postmarketing
|
|
|
x
|
|
Gastrointestinal disorder
|
Gastrointestinal disorder
|
postmarketing
|
|
|
x
|
|
Gastrointestinal symptom NOS
|
|
|
|
x
|
|
Glossodynia
|
Glossodynia
|
postmarketing
|
|
|
x
|
|
Gout
|
Gout
|
postmarketing
|
|
|
x
|
|
Cardiac arrest
|
Cardiac arrest
|
postmarketing
|
|
|
x
|
|
Cardiac failure congestive
|
Cardiac failure congestive
|
postmarketing
|
|
x
|
x
|
|
Haemorrhage
|
Haemorrhage
|
postmarketing
|
|
|
x
|
|
Haemoglobin
|
Haemorrhage
|
postmarketing
|
|
|
x
|
|
Hyperhidrosis
|
Hyperhidrosis
|
postmarketing
|
|
|
x
|
|
Sweating
|
postmarketing
|
|
|
x
|
|
Hyperkalaemia
|
Hyperkalaemia
|
postmarketing
|
|
|
x
|
|
Hypersensitivity
|
Hypersensitivity
|
postmarketing
|
|
x
|
x
|
|
Malignant hypertension
|
Malignant hypertension
|
postmarketing
|
|
|
x
|
|
Hyperventilation
|
Hyperventilation
|
postmarketing
|
|
|
x
|
|
Hypotension
|
Hypotension
|
postmarketing, 0.4% - 2.5%
|
|
x
|
x
|
|
Hypotensive
|
|
|
|
x
|
|
Immune system disorder
|
Immune system disorder
|
postmarketing
|
|
|
x
|
|
Renal failure chronic
|
Renal failure chronic
|
postmarketing
|
|
x
|
x
|
|
Laryngeal oedema
|
Laryngeal oedema
|
postmarketing
|
|
|
x
|
|
Mediastinal disorder
|
Mediastinal disorder
|
postmarketing
|
|
|
x
|
|
Myocardial infarction
|
Myocardial infarction
|
postmarketing
|
|
|
x
|
|
Acute coronary syndrome
|
Myocardial infarction
|
postmarketing
|
|
|
x
|
|
Nervous system disorder
|
Nervous system disorder
|
postmarketing
|
|
|
x
|
|
Night sweats
|
Night sweats
|
postmarketing
|
|
|
x
|
|
Pain
|
Pain
|
postmarketing
|
|
|
x
|
|
Paraesthesia
|
Paraesthesia
|
postmarketing
|
|
|
x
|
|
Prurigo
|
Prurigo
|
postmarketing
|
|
|
x
|
|
Swelling
|
Swelling
|
postmarketing
|
|
|
x
|
|
Shock
|
Syncope
|
postmarketing
|
|
x
|
x
|
|
Syncope
|
Syncope
|
postmarketing
|
|
x
|
x
|
|
Loss of consciousness
|
Syncope
|
postmarketing
|
|
x
|
x
|
|
Loss of consciousness
|
postmarketing
|
|
x
|
x
|
|
Tachycardia
|
Tachycardia
|
postmarketing
|
|
x
|
x
|
|
Urticaria
|
Urticaria
|
postmarketing
|
|
x
|
x
|
|
Angiopathy
|
Angiopathy
|
postmarketing
|
|
|
x
|
|
Vasodilation procedure
|
Vasodilation
|
postmarketing
|
|
|
x
|
|
Wheezing
|
Wheezing
|
postmarketing
|
|
|
x
|
|
Dry mouth
|
Dry mouth
|
postmarketing
|
|
|
x
|
|
Burning sensation
|
Burning sensation
|
postmarketing
|
|
|
x
|
|
Hepatic function abnormal
|
Hepatic function abnormal
|
postmarketing
|
|
|
x
|
|
Injection site reaction
|
Injection site reaction
|
postmarketing
|
|
|
x
|
|
Muscular weakness
|
Muscular weakness
|
postmarketing
|
|
|
x
|
|
Lacrimation increased
|
Lacrimation increased
|
postmarketing
|
|
|
x
|
|
Respiratory arrest
|
Respiratory arrest
|
postmarketing
|
|
|
x
|
|
Malnutrition
|
Malnutrition
|
postmarketing
|
|
|
x
|
|
Skin hyperpigmentation
|
Skin hyperpigmentation
|
postmarketing
|
|
|
x
|
|
Myalgia
|
Myalgia
|
postmarketing
|
|
|
x
|
|
Increased appetite
|
Increased appetite
|
postmarketing
|
|
|
x
|
|
Decreased appetite
|
Decreased appetite
|
postmarketing
|
|
|
x
|
|
Abdominal discomfort
|
Abdominal discomfort
|
postmarketing
|
|
|
x
|
|
Abdominal pain upper
|
Abdominal pain upper
|
postmarketing
|
|
|
x
|
|
Faeces discoloured
|
Faeces discoloured
|
postmarketing
|
|
|
x
|
|
Chest discomfort
|
Chest discomfort
|
postmarketing
|
|
|
x
|
|
Pharyngeal oedema
|
Pharyngeal oedema
|
postmarketing
|
|
|
x
|
|
Swollen tongue
|
Swollen tongue
|
postmarketing
|
|
|
x
|
|
Throat tightness
|
Throat tightness
|
postmarketing
|
|
|
x
|
|
Lip swelling
|
Lip swelling
|
postmarketing
|
|
|
x
|
|
Serum ferritin increased
|
Serum ferritin increased
|
postmarketing
|
|
x
|
x
|
|
Hypoxia
|
Hypoxia
|
postmarketing
|
|
|
x
|
|
Hepatobiliary disease
|
Hepatobiliary disease
|
postmarketing
|
|
|
x
|
|
Pulse absent
|
Pulse absent
|
postmarketing
|
|
x
|
x
|
|
Anaphylactoid reaction
|
Anaphylactoid reaction
|
postmarketing
|
|
|
x
|
|
Vision blurred
|
Vision blurred
|
postmarketing
|
|
|
x
|
|
Feeling hot
|
Warmth
|
postmarketing
|
|
|
x
|
|
Feeling hot
|
postmarketing
|
|
|
x
|
|
Musculoskeletal stiffness
|
Stiffness
|
postmarketing
|
|
|
x
|
|
Musculoskeletal stiffness
|
postmarketing
|
|
|
x
|
|
Pruritus generalised
|
Pruritus generalised
|
postmarketing
|
|
|
x
|
|
Rash generalised
|
Rash generalised
|
postmarketing
|
|
|
x
|
|
Injection site haemorrhage
|
Injection site bruising
|
postmarketing
|
|
|
x
|
|
Injection site bruising
|
Injection site bruising
|
postmarketing
|
|
|
x
|
|
Blood glucose decreased
|
Blood glucose decreased
|
postmarketing
|
|
|
x
|
|
Menopausal symptoms
|
Hot flush
|
postmarketing
|
|
|
x
|
|
Hot flush
|
Hot flush
|
postmarketing
|
|
|
x
|
|
Cardio-respiratory arrest
|
Cardio-respiratory arrest
|
postmarketing
|
|
x
|
x
|
|
Throat irritation
|
Throat irritation
|
postmarketing
|
|
|
x
|
|
Oxygen saturation decreased
|
Oxygen saturation decreased
|
postmarketing
|
|
|
x
|
|
Injection site pruritus
|
Injection site pruritus
|
postmarketing
|
|
|
x
|
|
Injection site discolouration
|
Injection site discolouration
|
postmarketing
|
|
|
x
|
|
Infusion site swelling
|
Infusion site swelling
|
postmarketing
|
|
x
|
x
|
|
Respiratory failure
|
Respiratory failure
|
postmarketing
|
|
|
x
|
|
Somnolence
|
Somnolence
|
postmarketing
|
|
|
x
|
Indications
Information about indications was extracted from the indications and usage sections of the labels.
| Side effects: | 33 |
| Source: | FDA Structured Product Label |
|---|
| Side effects: | 112 |
| Source: | EMA |
|---|
Color scheme:
standard – alternative
|
|
|
100%
|
|
|
|
75%
|
|
|
|
50%
|
|
|
|
10%
|
|
|
|
frequent (1% to 100%)
|
|
|
|
infrequent (0.1% to 1%)
|
|
|
|
rare (<0.1%)
|
|
|
|
postmarketing
|
|
|
|
0%
|
|
|
|
no frequency information
|
|
|
|
not found on label
|